Sanofi-Aventis Korea said Thursday that its monoclonal antibody dupilumab has shown positive outcomes in each phase 3 clinical trial on adults with prurigo nodularis and patients above 12 with eosinophilic esophagitis.In phase 3 PRIME2 trial, dupilumab significantly reduced itching and skin lesions
A joint research team of Korea Basic Science Institute (KBSI) and Incheon National University has created a platform for developing therapies for brain cancer, known as an incurable disease.The research team expects the platform will allow small cell chips to examine the interaction between glioblas
A research team at Seoul National University Hospital (SNUH) has found an optimal concentration of atropine therapy for slowing down myopia in children.The research team, led by Professors Kim Young-kook and Jung Jae-ho of the Department of Pediatric Ophthalmology, discovered that the 0.05 percent c
Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, following four similar studies in the past two years.The company had won the go-ahead to run four phase 1 clinical trials of its combo therapy candidate bef
Handok Pharmaceuticals has decided to conduct a clinical trial of ABL001, or CTX-009, a bispecific antibody targeting cancer cells, in the U.S. with its local partner, Compass Therapeutics.The two companies plan to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Admini
ABL Bio, a company developing bispecific antibody platforms, said its cancer immunotherapy candidate ABL103 has been selected by the government as part of the national new drug development project.The state-funded program aims to help companies efficiently enter clinical studies for candidate substa
JW Pharmaceutical said Tuesday that its dyslipidemia drug Rivaro (ingredient: pitavastatin) induced fewer side effects, such as diabetes, than other statin drugs through a study conducted in Taiwan.Researchers compared the cumulative risk of developing diabetes, hepatitis, and myopathy among partici
CubeBio, a company specializing in vitro diagnostics for early cancer detection, has advanced to the Russian market by signing an export contract.On Monday, the company said it signed an export contract with Russia’s Standart-Biotest and an investment agreement with the European Union at the Federat
A research team at the Institute for Basic Science (IBS) has developed a novel antibody that normalizes damaged vessels in patients, offering a therapeutic antibody mechanism by identifying it in a three-dimensional molecular structure.The research team expects the study results to help develop ther
EuBiologics said it has completed phase 3 clinical trials of its originally developed vaccine, EuTCV, against typhoid fever conducted in the Philippines.The company has been conducting studies to verify the efficacy of the typhoid vaccine in 444 healthy people aged six months to 45 years with De La
Decentralized clinical trials (DCT) are drawing attention as a new method to research by shortening the development period for new drugs and reducing time and cost amid the prolonged pandemic, according to industry insiders.Pharmaceutical companies face three major difficulties in conducting clinica
MSD said Friday that the company plans to supply molnupiravir, its oral Covid-19 therapy under development, to Korea by receiving emergency use authorization (EUA) from the local regulatory agency.MSD’s move comes as the Korean government negotiates with global pharmaceutical companies to import ora
Curacle said Friday that it has signed a 2.3 trillion won ($1.97 billion) licensing and collaboration agreement with Thea Open Innovation to develop oral therapy CUE06-RE for diabetic macular edema and wet age-related macular degeneration.Under the accord, Thea Open Innovation, a sister company of T
The Supreme Court, on Thursday, dismissed the appeal filed by Novartis against Hanmi Pharmaceutical and Ahngook Pharmaceutical over the patent extension term of Galvus (ingredient: vildagliptin), closing the four-year-long patent dispute.The recent ruling marks the first case of domestic pharmaceuti
Dong-A ST received regulatory approval to conduct its third phase 1 clinical trial of donepezil transdermal patch for treating Alzheimer’s disease to check for optimum dose in long-term attachment.The phase 1b clinical trial of DA-5207, the company’s donepezil patch, is an additional study requested
Maria Medical Technology (MMT), a manufacturer of aesthetic devices and medical robots based in the United Arab Emirates, has released an automated, artificial intelligence-based medical robot for hair removal, iLaser.MMT makes medical “cobots,” robots designed to work collaboratively with humans wi
Korean biotech companies are jumping into the drug contract manufacturing (CMO) business and increasing their production capacity to secure a stable source of income.Many bio ventures in the nation, such as Bioneer, Humedix, ViGenCell, and Genome & Company, have already begun expanding or preparing
A Korea Research Institute of Bioscience and Biotechnology (KRIBB) research team has found a clue to possibly inhibit the cancer cell proliferation in a study that revealed cell division processes caused by beta-catenin protein in humans.The team identified that beta-catenin protein, one of the main
Samsung Bioepis has completed the global phase 3 clinical trials of its SB12, a biosimilar drug of Soliris (ingredient: eculizumab), for treating paroxysmal nocturnal hemoglobinuria (PNH).The company received the last patient to end the clinical trials of SB12 and updated the study in clinicaltrials
Laypersons tend to think dermatologists are similar to cosmeticians. In extreme cases, however, people can die of skin diseases – especially if the ailment is malignant melanoma and if it spreads to internal organs. In the past, dermatology departments stopped at diagnosing problems through biopsies